HIGHLIGHTS
- who: Hui Li et al. from the Department of endocrine, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University have published the paper: Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials, in the Journal: Pharmaceuticals 2022, 15, x FOR PEER REVIEW of 24/07/2022
- what: The authors conducted a systematic review and network meta-analysis of randomized, controlled trials (RCT) to evaluate the clinical efficacy of the combination of CSII with six classes of oral GLDs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.